BD Executive and Leadership Team

Tom Polen, the Chairman, Chief Executive Officer & President at BD, directs the overarching strategic vision for the global medical technology enterprise. Polen architects long-term growth initiatives by prioritizing innovation in drug delivery and diagnostic systems. By aligning the executive leadership team with the core mission of improving patient safety, the Chairman, Chief Executive Officer & President ensures operational excellence across all international markets. This leadership role involves constant engagement with the Board to maintain high standards of corporate governance and financial performance. Through the integration of advanced biosciences and laboratory equipment, Tom Polen drives the company toward market leadership. Ultimately, Polen secures the competitive position of the organization by fostering a culture of continuous improvement and technological advancement within the healthcare sector.

Kathryn Wetzel, the Chief of Staff, Office of the CEO & SVP at BD, manages the operational flow and strategic priorities within the executive office. Wetzel architects communication channels that connect the CEO with various business units, ensuring that the mission of the company remains the primary focus. By overseeing special projects and high-level initiatives, the Chief of Staff, Office of the CEO & SVP facilitates the execution of corporate strategy across the global organization. This role involves coordinating with other C-suite leaders to ensure that departmental goals align with the overarching vision for medical technology innovation. Kathryn Wetzel supports the CEO in navigating complex organizational challenges and driving operational efficiency. Through the effective management of executive priorities, Wetzel ensures that the leadership team remains focused on delivering superior healthcare solutions.

Vitor Roque, the Executive Vice President & Chief Financial Officer at BD, manages the financial health and capital allocation strategies of the global medical technology firm. Roque architects fiscal policies that support the development and manufacturing of medical devices and diagnostic systems. By overseeing financial planning and analysis, the Executive Vice President & Chief Financial Officer ensures that resources are directed toward high-growth areas of the business. This role involves maintaining transparency with investors and ensuring compliance with international financial regulations. Vitor Roque collaborates with the executive team to evaluate the economic impact of new healthcare solutions and market expansions. Through the rigorous management of the balance sheet, Roque secures the financial foundation necessary for the company to continue its mission of advancing the world of health.

Ravi Dawar, the Director, Finance & Chief Financial Officer at BD, oversees the financial operations and reporting for specific business segments within the medical technology portfolio. Dawar architects budgeting processes that support the manufacturing and distribution of laboratory equipment and diagnostic systems. By monitoring financial performance metrics, the Director, Finance & Chief Financial Officer ensures that operational costs remain aligned with revenue targets. This role involves providing financial insights to the leadership team to guide decision-making regarding product development and market expansion. Ravi Dawar manages the financial risks associated with global supply chains and healthcare market fluctuations. Through the precise management of financial data, Dawar supports the overall fiscal health of the company and contributes to the successful execution of the corporate strategy.

Ivy Parks, the President (Canada) at BD, directs all commercial operations and strategic initiatives within the Canadian market. Parks architects local growth strategies that leverage the full range of medical devices and diagnostic systems offered by the company. By overseeing regional sales and distribution networks, the President (Canada) ensures that healthcare providers have access to the latest innovations in patient safety and drug delivery. This role involves building strong relationships with local health authorities and clinical partners to drive the adoption of medical technology solutions. Ivy Parks aligns regional activities with the global mission to improve patient outcomes. Through the effective management of the Canadian business unit, Parks strengthens the market presence of the company and contributes to the overall success of the organization in North America.

Sandra Ostler, the Chief Information Officer at BD, manages the digital infrastructure supporting global medical device manufacturing and diagnostic operations. Ostler designs secure data architectures that facilitate seamless information flow between hospitals and laboratory systems. By modernizing enterprise software, the Chief Information Officer enhances the efficiency of healthcare solutions provided to providers worldwide. This role requires close collaboration with the technology and operations teams to ensure data integrity and cybersecurity across all regional platforms. Sandra Ostler optimizes digital workflows to support the rapid development of new medical technologies. Through the implementation of scalable cloud solutions, Ostler strengthens the technological foundation of the company, ensuring that all digital assets remain aligned with the broader strategic goals of the organization.

Jillian Streeter, the Manager, Quality & Chief Marketing Officer, Instrument at BD, oversees the strategic positioning of laboratory equipment and diagnostic instrumentation. Streeter architects marketing campaigns that highlight the precision and reliability of the instrument portfolio. By integrating quality management protocols into the product lifecycle, the Manager, Quality & Chief Marketing Officer, Instrument ensures that all diagnostic systems meet rigorous clinical standards. This leadership role involves analyzing market trends to identify opportunities for expanding the reach of laboratory solutions. Jillian Streeter coordinates with product development teams to translate technical specifications into compelling value propositions for healthcare providers. Through the rigorous application of quality assurance, Streeter maintains the reputation of the company as a trusted partner in the global medical technology landscape.

John DeFord, the Executive Vice President & Chief Technology Officer at BD, leads the research and development efforts for medical devices and bioscience innovations. DeFord architects the technical roadmap that drives the creation of next-generation healthcare solutions. By overseeing the engineering teams, the Executive Vice President & Chief Technology Officer ensures that all new products address critical gaps in patient care and drug delivery. This role involves managing complex R&D pipelines and fostering partnerships with academic and clinical institutions to accelerate technological breakthroughs. John DeFord aligns technical development with the overarching business strategy to maintain a competitive edge in the medical technology market. Through the continuous pursuit of scientific excellence, DeFord advances the capabilities of the company in delivering life-saving medical equipment.

Devon Peterson, the Director and Chief of Staff To Chief Revenue Officer at BD, coordinates the strategic initiatives that drive revenue growth across the global medical technology portfolio. Peterson architects operational frameworks that streamline the sales process for diagnostic systems and medical devices. By facilitating communication between the revenue team and other executive functions, the Director and Chief of Staff To Chief Revenue Officer ensures alignment with corporate financial targets. This role involves analyzing sales performance data to optimize market penetration strategies in key regions. Devon Peterson supports the Chief Revenue Officer in executing high-level business plans that expand the footprint of the company among healthcare providers. Through the effective management of internal resources, Peterson contributes to the long-term financial stability and market success of the organization.

Meera Gopalakrishnan, the Senior Vice President and Global Chief Marketing Officer at BD, directs the global brand strategy and market engagement for the entire medical technology portfolio. Gopalakrishnan architects comprehensive marketing programs that communicate the value of diagnostic systems and laboratory equipment to healthcare providers. By analyzing global market dynamics, the Senior Vice President and Global Chief Marketing Officer ensures that the company maintains a strong presence in both established and emerging regions. This role involves leading cross-functional teams to develop customer-centric messaging that highlights the impact of medical innovations on patient safety. Meera Gopalakrishnan aligns marketing initiatives with the broader corporate mission to drive adoption of new healthcare solutions. Through strategic brand management, Gopalakrishnan strengthens the market position of the company as a leader in medical technology.